Search

Your search keyword '"Zou LQ"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Zou LQ" Remove constraint Author: "Zou LQ"
84 results on '"Zou LQ"'

Search Results

1. Flavonoids as therapeutic agents for epilepsy: unveiling anti-inflammatory and antioxidant pathways for novel treatments.

2. Reliability and Validity of the Chinese Version of the Revised Sociosexual Orientation Inventory.

3. Multiparametric MRI-based whole-liver radiomics for predicting early-stage liver fibrosis in rabbits.

4. Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis.

5. Effect of Iron Deposition on Native T1 Mapping and Blood Oxygen Level Dependent for the Assessment of Liver Fibrosis in Rabbits With Carbon Tetrachloride Intoxication.

6. Development and validation of the Olfactory Memory Test Battery (OMTB) based on odors with high- and low-verbalizability.

7. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.

8. Sniffing of Body Odors and Individual Significance of Olfaction Are Associated with Sexual Desire: A Cross-Cultural Study in China, India, and the USA.

9. Do you often sniff yourself or others? Development of the Body Odor Sniffing Questionnaire and a cross-cultural survey in China and the USA.

10. Nomograms to predict progression of disease within 24 months in patients with localized natural killer/T-cell lymphoma.

11. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.

12. Olfactory identification impairment in early-and late-onset obsessive-compulsive disorder.

13. A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study.

14. Odour identification impairment is a trait but not a disease-specific marker for bipolar disorders: Comparisons of bipolar disorder with different episodes, major depressive disorder and schizophrenia.

15. Clinical management and susceptibility of primary hepatic lymphoma: A cases-based retrospective study.

16. How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome.

17. Association between olfactory function and quality of life in patients with olfactory disorders: a multicenter study in over 760 participants.

18. Staging liver fibrosis on multiparametric MRI in a rabbit model with elastography, susceptibility-weighted imaging and T1ρ imaging: a preliminary study.

19. Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model.

20. Self-reported mini olfactory questionnaire (Self-MOQ): A simple and useful measurement for the screening of olfactory dysfunction.

21. Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.

22. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits.

23. Early-Onset Schizophrenia Showed Similar but More Severe Olfactory Identification Impairment Than Adult-Onset Schizophrenia.

25. Chemosensory Anhedonia in Patients With Schizophrenia and Individuals With Schizotypy: A Questionnaire Study.

26. Decreasing prevalence of specific anosmia to non-steroid odorants from childhood to adolescence.

27. The Chemosensory Pleasure Scale: A New Assessment for Measuring Hedonic Smell and Taste Capacities.

28. Immune checkpoint inhibitors: a new era for esophageal cancer.

29. Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma.

30. [Bortezomib Inhibits Extranodal Natural Killer/T Cell Lymphoma, Nasal Type by Targeting NF-κB Signaling Pathway].

31. Anticipatory pleasure for future rewards is attenuated in patients with schizophrenia but not in individuals with schizotypal traits.

32. Altered Functional Connectivity of the Default Mode Network in Patients With Schizo-obsessive Comorbidity: A Comparison Between Schizophrenia and Obsessive-compulsive Disorder.

33. Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity.

34. Pluronics modified liposomes for curcumin encapsulation: Sustained release, stability and bioaccessibility.

35. Olfactory identification deficit and its relationship with hedonic traits in patients with first-episode schizophrenia and individuals with schizotypy.

36. Neural responses during the anticipation and receipt of olfactory reward and punishment in human.

37. A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.

38. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.

39. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.

40. Serum B-cell activating factor predicts prognosis in nasal type, extranodal NK/T cell lymphoma.

41. The effects of working memory training on enhancing hedonic processing to affective rewards in individuals with high social anhedonia.

42. Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type.

43. The neural mechanism of hedonic processing and judgment of pleasant odors: An activation likelihood estimation meta-analysis.

44. [Recent advances in biosynthetic pathway and synthetic biology of taxol].

45. [Key technologies in synthetic biology of natural products].

46. [Advance in biosynthesis of terpenoid indole alkaloids and its regulation in Catharanthus roseus].

47. [Advance in flavonoids biosynthetic pathway and synthetic biology].

48. [Advance in transcriptomic studies of ginseng species].

49. [Strategies of elucidation of biosynthetic pathways of natural products].

50. Complete chloroplast genome sequence of the medicinal plant Gynostemma pentaphyllum .

Catalog

Books, media, physical & digital resources